Supplemental material
Journal of Asthma
Volume 59, 2022 - Issue 9
Open access
2,506
Views
7
CrossRef citations to date
0
Altmetric
Pharmacotherapy
Factors leading to discontinuation of biologic therapy in patients with severe asthma
Jared Silver,a GlaxoSmithKline, Research Triangle Park, NC, USAView further author information
, MD, Phd, Michael Bogart,a GlaxoSmithKline, Research Triangle Park, NC, USAView further author information
, Pharmd, Nestor A. Molfino,a GlaxoSmithKline, Research Triangle Park, NC, USAView further author information
, MD, Msc, James Siddall,b Adelphi Real World, Bollington, UKView further author information
, BA, Mark Small,b Adelphi Real World, Bollington, UKView further author information
, BSc, Matt Hanson,b Adelphi Real World, Bollington, UKView further author information
, MSc & Beth Hahn,a GlaxoSmithKline, Research Triangle Park, NC, USACorrespondence[email protected]
View further author information
, Phd show allView further author information
Pages 1839-1849
|
Received 23 Feb 2021, Accepted 18 Aug 2021, Published online: 06 Sep 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.